Patients with advanced stage of mixed liver cancer can be treated by targeted drug therapy, dietary adjustment and immunotherapy.
1. Targeted therapy: Liver cancer is one of the top malignant tumors in China in terms of morbidity and mortality. At present, patients with advanced liver cancer can be treated with targeted therapy, such as Lenvatinib, Regorafenib and other drugs. Targeted therapy can block the neovascularization of tumor growth and inhibit the growth of tumor.
2. Dietary adjustment: In the advanced stage of liver cancer, patients’ digestion and absorption functions are affected, so it is necessary to adjust the diet so that patients can take in enough nutrients. Patients should eat less and more meals to reduce their digestive burden; eat more easily digestible protein and vitamin foods, such as eggs, fish, vegetables and fruits.
3. Immunotherapy: through immunotherapy, patients’ immune cells can kill the tumor cells and inhibit the tumor. Immunotherapy drugs include nabumab, pembrolizumab and so on.
Patients with advanced stage of mixed liver cancer are recommended to undergo standardized treatment under the guidance of professional doctors, and must actively accept treatment and keep an optimistic mindset, which will help their condition recover.